Search bioRxiv⌕ Search

Biology subjects

Mendes, R.

Publications and source records attributed to Mendes, R..

2 recordsLinked to original sources

Uncovering functional deterioration in the rhizosphere microbiome associated with wheat dwarfing

BackgroundOne of the biggest developments of wheat domestication was the development of semi-dwarf cultivars that respond well to fertilisers and produce higher yields without lodging. Consequently, this change has also impacted the wheat microbiome, often resulting in reduced selection of taxa and a loss of network complexity in the rhizospheres of semi-dwarf cultivars. Given the importance of rhizosphere microbiomes for plant health and performance, it is imperative that we understand if and how these changes have affected their function. Here, we use shotgun metagenomics to classify the functional potential of prokaryote communities from the rhizospheres of tall and semi-dwarf cultivars to compare the impact of wheat dwarfing on rhizosphere microbiome functions. ResultsWe found distinct taxonomic and functional differences between tall and semi-dwarf wheat rhizosphere communities and identified that semi-dwarf wheat microbiomes were less distinct from bulk soil communities. Of the 113 functional genes that were differentially abundant between tall and semi-dwarf cultivars, 95 % were depleted in semi-dwarf cultivars and 65 % of differentially abundant reads best mapped to genes involved in staurosporine biosynthesis (antibiotic product), plant cell wall degradation (microbial mediation of plant root architecture, overwintering energy source for microbes) and sphingolipid metabolism (signal bioactive molecules). ConclusionsOverall, our findings indicate that green revolution breeding has developed wheat cultivars with a reduced rhizosphere effect. The consequences of this are likely detrimental to the development of microbiome-assisted agriculture which will require a strong rhizosphere selective environment for the establishment of a beneficial plant root microbiome. We believe our results are of striking importance and highlight that implementation of microbiome facilitated agriculture as part of a sustainable crop production strategy will require an overhaul of wheat breeding programmes to consider plant-microbe interactions, especially in the root environment.

microbiology↗

The Burden of Antimicrobial Resistance among Urinary Tract Isolates of Escherichia coli in the United States in 2017

Urinary tract infections (UTIs) caused by Escherichia coli have been historically managed with oral antibiotics including the cephalosporins, fluoroquinolones and trimethoprim-sulfamethoxazole. The use of these agents is being compromised by the increase in extended spectrum {beta}-lactamase (ESBL)-producing organisms, mostly caused by the emergence and clonal expansion of E. coli multilocus sequence typing (ST) 131. In addition, ESBL isolates show co-resistance to many of oral agents. Management of UTIs caused by ESBL and fluoroquinolone-resistant organisms is becoming increasingly challenging to treat outside of the hospital setting with clinicians having to resort to intravenous agents. The aim of this study was to assess the prevalence of ESBL phenotypes and genotypes among UTI isolates of E. coli collected in the US during 2017 as well as the impact of co-resistance to oral agents such as the fluoroquinolones and trimethoprim-sulfamethoxazole. The national prevalence of ESBL phenotypes of E. coli was 15.7% and was geographically distributed across all nine Census regions. Levofloxacin and trimethoprim-sulfamethoxazole-resistance rates were [≥] 24% among all isolates and this co-resistance phenotype was considerably higher among isolates showing an ESBL phenotype ([≥] 59.2%) and carrying blaCTX-M-15 ([≥] 69.5%). The agents with the highest potency against UTI isolates of E. coli, including ESBL isolates showing cross-resistance across oral agents, were the intravenous carbapenems. The results of this study indicate that new oral options with the spectrum and potency similar to the intravenous carbapenems would address a significant unmet need for the treatment of UTIs in an era of emergence and clonal expansion of ESBL isolates resistant to several classes of antimicrobial agents, including oral options.

microbiology↗